TEVA 22 10 (Sucralfate 1 g)
Pill imprint TEVA 22 10 has been identified as Sucralfate 1 g.
Sucralfate is used in the treatment of gerd; duodenal ulcer; stomach ulcer; stomatitis; hyperphosphatemia of renal failure (and more), and belongs to the drug class miscellaneous GI agents. There is no proven risk in humans during pregnancy. Sucralfate 1 g is not subject to the Controlled Substances Act.
See also related documents.
Images for TEVA 22 10 (Sucralfate 1 g)
More about sucralfate
- Other brands: Carafate